Morphine Adverse Reaction Completed Phase Trials for Naloxone (DB01183)

IndicationStatusPhase
DBCOND0043635 (Morphine Adverse Reaction)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00890942Efficacy of Intramuscular Naloxone 0.4mg. in Prophylaxis of Intrathecal Morphine Induced Pruritus After Cesarean SectionTreatment